These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 9146076)

  • 1. [Parkinsonism in a patient receiving interferon alpha therapy for chronic hepatitis C].
    Mizoi Y; Kaneko H; Oharazawa A; Kuroiwa H
    Rinsho Shinkeigaku; 1997 Jan; 37(1):54-6. PubMed ID: 9146076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Mononeuropathy multiplex in a patient receiving interferon alpha therapy for chronic hepatitis C].
    Maeda M; Ohkoshi N; Hisahara S; Mizusawa H; Shoji S
    Rinsho Shinkeigaku; 1995 Sep; 35(9):1048-50. PubMed ID: 8565346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A case of myasthenia gravis which developed myasthenic crisis after alpha-interferon therapy for chronic hepatitis C].
    Konishi T
    Rinsho Shinkeigaku; 1996 Aug; 36(8):980-5. PubMed ID: 8958752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A case of subcutaneous sarcoid nodules induced by interferon-alpha].
    Ohhata I; Ochi T; Kurebayashi S; Masutani H; Kikui M
    Nihon Kyobu Shikkan Gakkai Zasshi; 1994 Oct; 32(10):996-1000. PubMed ID: 7844919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Autoimmune hemolytic anemia reactivated by alpha-interferon therapy in a case of chronic active C-type hepatitis].
    Katayama T; Naitou Y; Kusaka M; Ochiai S; Yoshida M; Kaito K; Masuoka H; Shimada T; Nishiwaki K; Kobayashi M
    Rinsho Ketsueki; 1995 Apr; 36(4):339-46. PubMed ID: 7783339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A case of chronic hepatitis C complicated by ischemia-like changes seen on the electrocardiogram during interferon treatment].
    Yamazaki K; Amishima M; Fujita J; Aida A; Aoi K; Miyamoto K; Kawakami Y
    Kokyu To Junkan; 1993 Aug; 41(8):805-9. PubMed ID: 8351443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Complete cytogenetic response to interferon-alpha in a patient with chronic myelogenous leukemia undergoing hemodialysis].
    Doi S; Edamura S; Akasaka H; Kawamura M; Arima N; Nasu K
    Rinsho Ketsueki; 2001 Jul; 42(7):549-53. PubMed ID: 11524845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Peripheral neuropathy during a second cycle of treatment with high doses of interferon-alpha in a patient with hepatitis C, and a review of the literature].
    Téllez-Zenteno JF; Negrete-Pulido O; Nuñez M; Estañol-Vidal B; García-Ramos G
    Rev Neurol; 2002 Oct 1-15; 35(7):644-6. PubMed ID: 12389150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is interferon-alpha therapy safe and effective for patients with chronic hepatitis C and inflammatory bowel disease? A case-control study.
    Bargiggia S; Thorburn D; Anderloni A; Ardizzone S; Giorgi A; Bianchi Porro G; Parente F
    Aliment Pharmacol Ther; 2005 Aug; 22(3):209-15. PubMed ID: 16091058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon-alpha therapy within the first year after acute hepatitis C infection in hemodialysis patients: efficacy and tolerance.
    Rocha CM; Perez RM; Narciso JL; Ferreira AP; Lemos LB; Medina-Pestana JO; Silva AE; Ferraz ML
    Eur J Gastroenterol Hepatol; 2007 Feb; 19(2):119-23. PubMed ID: 17272996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case of seizures 1 week after the cessation of interferon-alpha therapy.
    Seno H; Inagaki T; Itoga M; Miyaoka T; Ishino H
    Psychiatry Clin Neurosci; 1999 Jun; 53(3):417-20. PubMed ID: 10459745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Axonal neuropathy in a patient receiving interferon-alpha therapy for chronic hepatitis C.
    Tambini R; Quattrini A; Fracassetti O; Nemni R
    J Rheumatol; 1997 Aug; 24(8):1656-7. PubMed ID: 9263170
    [No Abstract]   [Full Text] [Related]  

  • 13. Efficacy of prolonged interferon therapy for patients with chronic hepatitis C with HCV-genotype 1b and high virus load.
    Arase Y; Ikeda K; Tsubota A; Suzuki Y; Saitoh S; Kobayashi M; Kobayashi M; Suzuki F; Akuta N; Someya T; Kumada H
    J Gastroenterol; 2003; 38(2):158-63. PubMed ID: 12640530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe exacerbation of hepatitis C-associated vasculitic neuropathy following treatment with interferon alpha: a case report and literature review.
    Boonyapisit K; Katirji B
    Muscle Nerve; 2002 Jun; 25(6):909-13. PubMed ID: 12115983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Polymyositis after interferon beta treatment of chronic hepatitis type C].
    Iguchi H; Kishi M; Fujioka T; Wakata N; Kinoshita M
    Rinsho Shinkeigaku; 1996 Jan; 36(1):22-4. PubMed ID: 8689784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II clinical trial of combined natural interferon-beta plus recombinant interferon-gamma treatment of chronic hepatitis B.
    Musch E; Högemann B; Gerritzen A; Fischer HP; Wiese M; Kruis W; Malek M; Gugler R; Schmidt G; Huchzermeyer H; Gerlach U; Dengler HJ; Sauerbruch T
    Hepatogastroenterology; 1998; 45(24):2282-94. PubMed ID: 9951911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of myasthenia gravis after interferon alpha therapy.
    Gurtubay IG; Morales G; Aréchaga O; Gállego J
    Electromyogr Clin Neurophysiol; 1999 Mar; 39(2):75-8. PubMed ID: 10207675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A-56-year-old woman with parkinsonism, whose mother had Parkinson's disease].
    Shimo Y; Takanashi M; Ohta S; Terashima K; Mori H; Shirai T; Miwa H; Mizuno Y
    No To Shinkei; 2001 May; 53(5):495-505. PubMed ID: 11428377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies of the effectiveness of interferon alpha treatment for chronic hepatitis C in children.
    Czerwionka-Szaflarska M; Chrobot A; Szaflarska-Szczepanik A
    Med Sci Monit; 2000; 6(5):964-70. PubMed ID: 11208439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hashimoto's disease during interferon-alpha therapy in a patient with pre-treatment negative anti-thyroid autoantibodies and with the specific genetic susceptibility to the thyroid disease.
    Martocchia A; Labbadia G; Paoletti V; Gargano S; Grossi A; Trabace S; Musca A; Falaschi P
    Neuro Endocrinol Lett; 2001; 22(1):49-52. PubMed ID: 11335880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.